Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$1.21B |
| 2 |
Labcorp
LH
|
+$608M |
| 3 |
Elevance Health
ELV
|
+$602M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$575M |
| 5 |
Netflix
NFLX
|
+$485M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$661M |
| 2 |
MetLife
MET
|
+$660M |
| 3 |
Cigna
CI
|
+$472M |
| 4 |
Mohawk Industries
MHK
|
+$462M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$263M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.94% |
| 2 | Consumer Discretionary | 14.42% |
| 3 | Communication Services | 11.46% |
| 4 | Financials | 8.97% |
| 5 | Materials | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$4.18T
| $2.3B | 8.82% |
73,120,240
-4,553,780
| -6% | -$140M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $1.96B | 7.5% |
7,202,384
+398,350
| +6% | +$122M |
|
|
WBA
3
DELISTED
Walgreens Boots Alliance
WBA
| $1.93B | 7.41% |
23,272,886
-1,352,227
| -5% | -$122M |
|
4
Amazon
AMZN
$2.79T
| $1.54B | 5.92% |
60,355,280
+14,704,060
| +32% | +$372M |
|
|
BRCM
5
DELISTED
BROADCOM CORP CL-A
BRCM
| $1.21B | 4.65% |
+23,568,995
| New | +$1.21B |
|
6
LyondellBasell Industries
LYB
$21.8B
| $1.13B | 4.31% |
13,505,956
+2,779,572
| +26% | +$247M |
|
7
Bausch Health
BHC
$2.41B
| $891M | 3.41% |
4,993,353
+376,615
| +8% | +$87.8M |
|
8
Broadcom
AVGO
$1.75T
| $868M | 3.32% |
69,394,870
+21,704,730
| +46% | +$274M |
|
|
9
Elevance Health
ELV
$86.9B
| $828M | 3.17% |
5,913,640
+4,006,939
| +210% | +$602M |
|
|
PXD
10
DELISTED
Pioneer Natural Resource Co.
PXD
| $811M | 3.11% |
6,663,287
+272,035
| +4% | +$33.9M |
|
11
Air Products & Chemicals
APD
$67.9B
| $755M | 2.89% |
6,396,516
+12,434
| +0.2% | +$1.58M |
|
12
Humana
HUM
$45.5B
| $690M | 2.64% |
3,853,454
+646,615
| +20% | +$120M |
|
13
Cheniere Energy
LNG
$57.3B
| $631M | 2.42% |
13,058,335
+1,733,943
| +15% | +$107M |
|
14
Canadian Pacific Kansas City
CP
$85B
| $597M | 2.29% |
20,808,210
-5,572,765
| -21% | -$168M |
|
|
15
Labcorp
LH
$27.3B
| $548M | 2.1% |
+5,882,098
| New | +$608M |
|
|
16
Teva Pharmaceuticals
TEVA
$43.5B
| $501M | 1.92% |
+8,872,650
| New | +$575M |
|
17
Mastercard
MA
$509B
| $489M | 1.87% |
5,427,711
-2,790,985
| -34% | -$262M |
|
|
18
Netflix
NFLX
$331B
| $466M | 1.79% |
+45,172,020
| New | +$485M |
|
19
McKesson
MCK
$100B
| $421M | 1.61% |
2,274,228
+1,648,660
| +264% | +$349M |
|
|
BNY
20
Bank of New York Mellon
BNY
$108B
| $403M | 1.54% |
10,289,868
+1,876,577
| +22% | +$78M |
|
|
SEE
21
DELISTED
Sealed Air
SEE
| $402M | 1.54% |
8,582,498
-4,235,531
| -33% | -$219M |
|
|
AET
22
DELISTED
Aetna Inc
AET
| $381M | 1.46% |
3,479,173
+381,574
| +12% | +$44.1M |
|
|
EVHC
23
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $363M | 1.39% |
3,291,456
-817,969
| -20% | -$101M |
|
|
24
Mohawk Industries
MHK
$9.23B
| $360M | 1.38% |
1,979,371
-2,331,742
| -54% | -$462M |
|
25
Crown Castle
CCI
$32.1B
| $355M | 1.36% |
4,496,338
-1,034,014
| -19% | -$84.1M |
|
Similar funds
Andreas Halvorsen's Q3 2015 Portfolio in Review
As of Q3 2015, Andreas Halvorsen held 78 positions worth $26.1B, down 1.4% from $26.5B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Andreas Halvorsen deployed $1.92B of net new capital in Q3 2015, opening 23 new positions and adding to 19 existing holdings. Its largest new stake was BROADCOM CORP CL-A: 23,568,995 shares worth $1.21B.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Illumina, an estimated $661M trimmed.
- Andreas Halvorsen's largest Q3 2015 buy was BROADCOM CORP CL-A: 23,568,995 shares worth $1.21B.
- Andreas Halvorsen added most to Elevance Health in Q3 2015, an estimated $602M increase.
- Andreas Halvorsen's biggest Q3 2015 reduction was Illumina, cutting an estimated $661M.
- Andreas Halvorsen fully exited MetLife in Q3 2015, selling an estimated $660M.
- Andreas Halvorsen's ten largest holdings make up 52% of its $26.1B portfolio in Q3 2015.
- Andreas Halvorsen opened 23 new positions and closed 16 in Q3 2015.
- Andreas Halvorsen's portfolio value fell 1.4% quarter-over-quarter to $26.1B.
Based on Viking Global Investors's 13F filing for Q3 2015, filed 16 Nov 2015.